| Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer. | |
| | |
MedLine Citation:
|
PMID: 17013719 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND/PURPOSE: The purpose of this study was to estimate the usefulness of positron emission tomography (PET) in deciding on strategies for the treatment of pancreatic cancer. The following two parameters were evaluated: the ability of PET to provide an estimation of the progression of pancreatic cancer, and the ability of PET to predict survival and the effect of chemoradiotherapy. METHODS: Forty-two patients underwent PET as part of the procedure for making a diagnosis of pancreatic tumors. The maximum standardized uptake value (SUVmax) levels were compared with clinicopathological factors and analyzed. RESULTS: PET provided a sensitivity of 87%, a specificity of 67%, and an overall accuracy of 85% for the diagnosis of pancreatic malignancy. Tumors with distant metastases showed significantly higher SUV levels than tumors without metastasis. In the patients who received chemoradiotherapy, the overall survival of the group in which SUVmax was less than 7.0 was better than that of the group in which SUVmax was more than 7.0. CONCLUSIONS: We conclude that PET is a useful tool for determining pathological status and distant metastasis in pancreatic cancer, and for predicting the prognosis of patients receiving chemoradiotherapy. |
| | |
Authors:
|
Kosei Maemura; Sonshin Takao; Hiroyuki Shinchi; Hidetoshi Noma; Yukou Mataki; Hiroshi Kurahara; Seishi Jinnouchi; Takashi Aikou |
Related Documents
:
|
9274129 - Breast cancer seeking agents: basic approach. 1692759 - Quantitative features of chromatin structure in the prognosis of breast cancer. 15902359 - Positron emission tomography: useful in detecting metastatic cancer of unknown primary ... 3850759 - Inability of caliper measurement to enhance observer agreement in the interpretation of... 11227949 - Solitary pancreatic metastasis from a primary colonic tumor detected by pet scan: repor... 12932109 - Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission t... 20219069 - Cd133 expression in rectal cancer after preoperative chemoradiotherapy. 22762409 - Sclerostin: a possible target for the management of cancer-induced bone disease. 20571599 - The paraneoplastic limbic encephalitis: mri characterization of a deceiving neurologica... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of hepato-biliary-pancreatic surgery Volume: 13 ISSN: 0944-1166 ISO Abbreviation: J Hepatobiliary Pancreat Surg Publication Date: 2006 |
Date Detail:
|
Created Date: 2006-10-02 Completed Date: 2007-03-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9431940 Medline TA: J Hepatobiliary Pancreat Surg Country: Japan |
Other Details:
|
Languages: eng Pagination: 435-41 Citation Subset: IM |
Affiliation:
|
Department of Surgical Oncology and Digestive Surgery, Field of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Combined Modality Therapy Decision Making Disease Progression Female Humans Male Middle Aged Neoplasm Metastasis Pancreatic Neoplasms / mortality, radionuclide imaging*, therapy* Positron-Emission Tomography* Prognosis Sensitivity and Specificity |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Analysis of bile duct injuries (Stewart-Way classification) during laparoscopic cholecystectomy.
Next Document: Type-2 dominant cytokine gene expression following hepatic surgery.